E-cigarette use among patients of smoking-related cancers in the United States.

Authors

Oladimeji Akinboro

Oladimeji Akinboro

Boston University Medical Center, Boston, MA

Oladimeji Akinboro , Rawad Elias , Stanley Madu Nwabudike , Oluseyi Balasire , Jamie S. Ostroff

Organizations

Boston University Medical Center, Boston, MA, Boston Medical Center, Boston, MA, Meharry Medical College, Nashville, TN, Memorial Sloan Kettering Cancer Center, New York, NY

Research Funding

Other

Background: The prevalence of e-cigarette use, and its impact on smoking cessation, among cancer survivors in the United States is unknown. We sought to estimate the prevalence of e-cigarette use, and examine its associations with cigarette smoking and quit attempts among survivors of smoking-related cancer survivors in the United States. Methods: We obtained data from the 2014-2016 annual cycles of the National Health Interview Survey. Our study sample comprised 2,561 adults with self-reported lifetime histories of at least one smoking-related cancer. We calculated the prevalence rates of e-cigarette use among survivors of smoking-related cancers. Using a multivariable logistic regression model, we examined independent associations of cigarette smoking history with e-cigarette use while adjusting for sociodemographic and other patient variables that were associated with e-cigarette use from the bivariate analyses. Survey weights were applied in estimating the population-based prevalence rates, odds ratios (OR), and 95% confidence intervals (CI). Results: The prevalence of e-cigarette use among survivors of smoking-related cancers was 3.31% (95% CI 2.39%, 4.56%). Those aged 18-44 years had the highest rates of e-cigarette use of any age group (7.26%; 95% CI 2.80%, 11.72%; p-value for age: < 0.001). No associations were seen between e-cigarrete use and gender, race, presence of other smoking-related comorbidities, or duration of survival. Current cigarette smokers were 31 times as likely as never smokers to use e-cigarettes (OR 31.48; 95% CI 4.54, 218.16). Among current smokers, no association was seen between e-cigarette use and either the number of quit attempts or smoking cessation counselling by health professional in the prior year. Conclusions: E-cigarette use was highest among current smokers and relatively young survivors of smoking related cancers. The lack of association between e-cigarette use and smoking quit attempts supports observations that e-cigarettes do not increase smoking quit rates. This is concerning, and highlights the need for further studies to define the impact of e-cigarette use on smoking cessation, and long-term outcomes of survivors of smoking-related cancers.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Patient and Survivor Care

Track

Patient and Survivor Care

Sub Track

Health Promotion

Citation

J Clin Oncol 36, 2018 (suppl; abstr 10052)

DOI

10.1200/JCO.2018.36.15_suppl.10052

Abstract #

10052

Poster Bd #

40

Abstract Disclosures

Similar Abstracts

Abstract

2022 ASCO Annual Meeting

Smoking cessation after cancer diagnosis: Relationships matter.

First Author: Melissa Francoise Neumann

First Author: Elyse R. Park

Abstract

2023 ASCO Annual Meeting

Rural disparities in telemedicine use among cancer survivors during the COVID-19 pandemic.

First Author: Min Jee Lee

Abstract

2024 ASCO Quality Care Symposium

Call to quit: Results of a remote, longitudinal tobacco cessation program.

First Author: Rebekah Kaufman